Antiretroviral HIV treatment and care for injecting drug users: An evidence-based overview

This publication has 45 references indexed in Scilit:

• Antiretroviral treatment for injecting drug users in developing and transitional countries 1 year before the end of the ‘Treating 3 million by 2005. Making it happen. The WHO strategy’ (‘3by5’)*
  Addiction, 2006
• Survival and progression to AIDS in a seroconverter cohort in the post-highly active antiretroviral therapy era: effectiveness goes on
  AIDS, 2006
• Illicit Drug Use and HIV-1 Disease Progression: A Longitudinal Study in the Era of Highly Active Antiretroviral Therapy
  American Journal of Epidemiology, 2006
• Evidence for Action: A critical tool for guiding policies and programmes for HIV prevention, treatment and care among injecting drug users
  International Journal of Drug Policy, 2005
• Do HIV Disease Progression and HAART Response Vary among Injecting Drug Users in Europe?
  European Journal of Epidemiology, 2005
• Treatment of Opioid Dependence and Coinfection with HIV and Hepatitis C Virus in Opioid- Dependent Patients: The Importance of Drug Interactions between Opioids and Antiretroviral Agents
  Clinical Infectious Diseases, 2005
• Long-term Outcome of Chronic Drug Use: The Amsterdam Cohort Study among Drug Users
  American Journal of Epidemiology, 2005
• Causes of death in HIV infection
  AIDS, 2004
• Determinants of survival following HIV-1 seroconversion after the introduction of HAART
  The Lancet, 2003
• Access to antiretroviral treatment among French HIV infected injection drug users: the influence of continued drug use. MANIF 2000 Study Group
  Journal of Epidemiology and Community Health, 1999